November 25th 2024
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from last week, all in one place.
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Nirsevimab recommended by FDA Advisory Committee to prevent RSV in infants
June 9th 2023In unanimous fashion, the FDA AMDAC voted 21 to 0 that nirsevimab has a favorable benefit risk profile for the prevention of RSV lower respiratory tract disease (LRTD) in newborns and infants during their first RSV season.
How AI can help detect and monitor coughing in infants and young children
May 31st 2023Devan Jaganath, MD, MPH, pediatric infectious disease physician, University of California San Francisco Benioff Children's Hospitals, explains how Hyfe AI and other artificial intelligence algorithms can detect and monitor coughing, potentially playing a role in treating RSV patients.
Pfizer's infant RSV vaccine receives FDA Advisory Committee's support
May 19th 2023The FDA Advisory Committee recently voted in support of approval for Pfizer's maternal immunization vaccine to help prevent RSV in infants. In this Contemporary Pediatrics® interview, Tina Tan, MD, FAAP, FIDSA, FPIDS, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital, Chicago, explains what this means for this patient population ahead of an expected FDA decision in August, 2023.
Establishing accurate case definitions for childhood respiratory and skin conditions
February 17th 2023A research letter addresses the challenges of accurately diagnosing asthma, atopic eczema, and allergic rhinitis in children under 5 years old and the use of Read codes and prescription data as diagnostic criteria.
Air pollution in urban areas linked to asthma, inflammatory responses in children
January 31st 2023The specific mechanisms involved in associations between air pollution and respiratory illness without viral infection are not understood, especially compared with those of respiratory viruses and asthma exacerbation.
FDA launches “Next Legend” e-cigarette prevention campaign for American indigenous youth
June 9th 2022The FDA recently announced an e-cigarette prevention campaign aimed at Native American and Alaskan Native youth using prominent social media sites and traditional media like billboards, radio, and TV.
Pulse oximetry may fail to detect hypoxemia in Black kids more often than in White kids
April 27th 2022Previous investigation has shown that common measurements and tools may not be as accurate in non-White patients as they are in White patients. A new investigation dives into whether pulse oximetry falls into this category.
Which ELGANs are most at risk of low lung function?
April 4th 2022An investigation examines what demographic factors and less-than-optimal respiratory support in or beyond the neonatal intensive care unit can increase the risk of abnormal lunch function on extremely low gestational age newborns (ELGANs).